Geschützte Warennamen (Warenzeichen®) werden nicht immer besonders kenntlich gemacht.
Aus dem Fehlen eines solchen Hinweises kann also nicht geschlossen werden, dass es …

Applikation therapeutischer (anthelminthischer) Dosierungen zu keinen zentralnervösen
Nebenwirkungen kommt. Genetische Veränderungen von P-Glykoprotein, wie sie z. B. bei …

Welches Analgetikum passt zu meinem Patienten? Mit welchen Nebenwirkungen muss ich
rechnen? Und in welchem Fall sollte ich von der Verwendung Abstand nehmen? Gründlich …

Background Complement is likely to have a role in refractory generalised myasthenia gravis,
but no approved therapies specifically target this system. Results from a phase 2 study …

Epilepsy is the tendency to have unprovoked epileptic seizures. Anything causing structural
or functional derangement of brain physiology may lead to seizures, and different conditions …

… Wolfgang Löscher … Rogawski, MA & Löscher, W. The neurobiology of antiepileptic
drugs for the treatment of nonepileptic conditions. Nature Med. …

Animal models for seizures and epilepsy have played a fundamental role in advancing our
understanding of basic mechanisms underlying ictogenesis and epileptogenesis and have …

It has been estimated that about 20% of patients with epilepsy cannot be treated successfully
with current antiepileptic drugs14”. It should be emphasized, however, that this global …

Resistance to drug treatment is an important hurdle in the therapy of many brain disorders,
including brain cancer, epilepsy, schizophrenia, depression and infection of the brain with HIV…

The blood-brain barrier (BBB) contributes to brain homeostasis by protecting the brain from
potentially harmful endogenous and exogenous substances. BBB active drug efflux …